ASX Market Wrap – May 30, 2025: A Tepid Friday as Energy and Tech Pull Back, HealthCo and Meeka Shine
The ASX 200 slipped 0.20% to close at 8,392.9 on Friday, as broad-based sector weakness kept investor sentiment subdued ahead of the weekend. While nine out of eleven sectors ended lower, gains in staples (+0.32%) and healthcare (+0.03%) helped cushion some of the losses. The All Ords fell 0.22% to 8,618.8, while the Small Ords dipped 0.25% to 3,206.6.
Information technology (-1.00%) and energy (-0.92%) led the sectoral laggards, with the ASX All Technology Index slipping 0.73% to 3,990.6. Real estate (-0.89%) and discretionary stocks (-0.40%) also faced selling pressure, reflecting broader caution in the market.
The standout performer of the day was HealthCo Healthcare and Wellness REIT (HCW), which surged 15.15% to $0.95 after striking a partial rent deferral agreement with Healthscope and its receivers. The agreement secures 85% of rents from June to August 2025, while deferring the remaining 15% until September. This provides much-needed clarity for HCW investors, especially as Healthscope, Australia’s second-largest private hospital operator, grapples with a $1.6 billion debt load.
Uranium stocks saw mixed action after Citi analysts switched their uranium sector preference from Boss Energy to Paladin Energy (PDN). While both remain Buy-rated, the analysts argue Paladin is oversold relative to uranium price moves, citing operational challenges and flooding issues that have weighed on the stock. Paladin shares rose 4.17% to $5.805, while Boss Energy edged lower. Citi’s call underscores expectations of a bullish uranium cycle, driven by supply tightness and renewed nuclear demand.
Gold stocks continued to attract attention, with Meeka Metals (MEK) rising 3.70% to $0.14. The company announced that its Murchison Gold Project’s plant expansion is nearing completion, with first gold targeted for mid-2025. Meeka projects average annual gold sales of 65koz over the first seven years, fully exposed to gold price movements.
India-based digital payments firm Findi Ltd (FND) saw its shares dip 5.35% to $4.78 despite reporting strong FY25 results. Revenue rose 13.5% to $75.5 million, with EBITDA up 14.4%. The company highlighted a boost from India’s central bank increasing interchange fees and remains on track for a 2026 IPO.
Among top gainers, Iperionx Ltd (IPX) rose 5.73%, Titomic Ltd (TTT) gained 5.26%, and Catapult Group (CAT) added 4.56%. On the flip side, Jumbo Interactive (JIN) tumbled 5.54%, followed by Findi (FND) and Brainchip (BRN), down 4.65%.
Wall Street’s mixed signals overnight failed to inspire ASX bulls. The S&P 500 edged 0.40% higher, while the Dow Jones gained 0.28%. However, concerns lingered over Trump-era tariffs, weak US consumer spending, and a modest 0.2% decline in US Q1 GDP.
Commodities were mixed, with Brent crude falling 1.26% to $64.08, while gold firmed 0.61% to $3,315.10 per ounce.
With the S&P/ASX 200 VIX Index at 10.4, volatility is expected to remain low in the short term, suggesting a market poised for consolidation rather than sharp moves. Investors will be watching upcoming economic data and earnings updates for fresh catalysts.
Disclaimer - Skrill Network is designed solely for educational and informational use. The content on this website should not be considered as investment advice or a directive. Before making any investment choices, it is crucial to carry out your own research, taking into account your individual investment objectives and personal situation. If you're considering investment decisions influenced by the information on this website, you should either seek independent financial counsel from a qualified expert or independently verify and research the information.
Tags:
RECENT POSTS
TAGS
Subscribe to the Skrill Network Newsletter today and stay informed
Recommended Articles